Literature DB >> 12417602

Mutation and expression of the beta-catenin-interacting protein ICAT in human colorectal tumors.

Toru Koyama1, Ken-Ichi Tago, Tsutomu Nakamura, Susumu Ohwada, Yasuo Morishita, Jun Yokota, Tetsu Akiyama.   

Abstract

BACKGROUND: Aberrant activation of Wnt signaling caused by mutations in the tumor suppressor adenomatous polyposis coli or beta-catenin is a critical event in the development of human colorectal tumors. We have recently identified the ICAT gene, which encodes a small protein that interacts with beta-catenin and represses Wnt signaling.
METHODS: We examined the prevalence of mutations in the entire ICAT coding sequence and intronic splice donor and acceptor regions of ICAT by PCR-SSCP and also the expression of the ICAT gene by RT-PCR.
RESULTS: The ICAT gene was mapped to chromosome 1p36.1-p36.2, which is implicated in the pathogenesis of various types of cancers. However, no mutations in ICAT were detected among 128 colorectal tumors. Instead, ICAT was found to be overexpressed in almost half of colorectal carcinomas. Cases exhibiting ICAT overexpression showed a significantly higher incidence of well-differentiated adenocarcinoma and positive lymphatic permeation.
CONCLUSION: Our results suggest that ICAT is not the putative tumor suppressor on 1p36.1-p36.2, although aberrant overexpression of ICAT may play a role in the pathogenesis of colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417602     DOI: 10.1093/jjco/hyf068

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  6 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

2.  Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation.

Authors:  Yaohui Chen; Yu Li; Jianfei Xue; Aihua Gong; Guanzhen Yu; Aidong Zhou; Kangyu Lin; Sicong Zhang; Nu Zhang; Cara J Gottardi; Suyun Huang
Journal:  EMBO J       Date:  2016-02-24       Impact factor: 11.598

3.  Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.

Authors:  Yayun Jiang; Wei Ren; Weijia Wang; Jing Xia; Liyao Gou; Mengyao Liu; Qun Wan; Lan Zhou; Yaguang Weng; Tongchuan He; Yan Zhang
Journal:  Oncol Rep       Date:  2017-09-18       Impact factor: 3.906

4.  RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.

Authors:  Yingyue Cao; Jianxiong Geng; Xin Wang; Qingwei Meng; Shanqi Xu; Yaoguo Lang; Yongxu Zhou; Lishuang Qi; Zijie Wang; Zixin Wei; Yan Yu; Shi Jin; Bo Pan
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

5.  MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.

Authors:  Ying Zhang; Tao Li; Pengbo Guo; Jia Kang; Qing Wei; Xiaoqing Jia; Wei Zhao; Wanwan Huai; Yumin Qiu; Lei Sun; Lihui Han
Journal:  Sci Rep       Date:  2014-09-01       Impact factor: 4.379

6.  Overexpression of ICAT Inhibits the Progression of Colorectal Cancer by Binding with β-Catenin in the Cytoplasm.

Authors:  Jiancong Hu; Zihan Wang; Junxiong Chen; Zhaoliang Yu; Jingdan Zhang; Weiqian Li; Mengmeng Lin; Xiangling Yang; Huanliang Liu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.